combination immunotherapiesHCCadvanced hepatocellular carcinoma
…encing (CITE-seq) to identify circulating immune biomarkers for combination immunotherapies in advanced hepatocellular carcinoma (HCC). While the original …
Entity family
Clinical therapies and care approaches used to manage a condition. Examples include immunotherapy, radiotherapy, rehabilitation.
This treatment is selected. Its supporting articles are shown below.
…encing (CITE-seq) to identify circulating immune biomarkers for combination immunotherapies in advanced hepatocellular carcinoma (HCC). While the original …
…tory circuits, logic gating and potency enhancements as well as combination immunotherapies are expected to further augment efficacy while maintaining safe…